Leica Biosystems Newcastle Ltd

FDA Filings

This page includes the latest FDA filings for Leica Biosystems Newcastle Ltd. Currently, you will find the latest 25 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

Latest Premarket Notifications

ManufacturerDevice NameDate
Leica Biosystems Newcastle Ltd.
BOND Ready-to-Use Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16 (Concentrated Liquid Antibody Format).2020-03-06
Leica Biosystems Newcastle Limited
BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16) , Novocastra Concentrated Liquid Mouse Monoclonal Antibody2018-12-07
Leica Biosystems Newcastle Limited
Estrogen Receptor Clone 6F11 Ready-to-Use Primary Antibody For Bond, Estrogen Receptor Clone 6F11 Liquid Concentrate Primary Antibody, Novocastra2018-12-07
Leica Biosystems Newcastle Limited
BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 162017-07-21
LEICA BIOSYSTEMS NEWCASTLE LTD
VISION BIOSYSTEMS ESTROGEN RECEPTOR CLONE 6F11 (ER 6F11)2014-05-19

Latest Premarket Applications

PMAManufacturerDevice NameDate

Latest De Novo Filings

De NovoManufacturerDevice NameDate

GUDID Registrations

Device GUDID
Device Name
ManufacturerDate
BOND™
LEICA BIOSYSTEMS NEWCASTLE LTD2018-03-29
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD2018-03-29
BOND™
LEICA BIOSYSTEMS NEWCASTLE LTD2018-03-29
BOND™
LEICA BIOSYSTEMS NEWCASTLE LTD2018-03-29
Novocastra™
LEICA BIOSYSTEMS NEWCASTLE LTD2018-03-29
BOND ORACLE HER2 IHC System
LEICA BIOSYSTEMS NEWCASTLE LTD2018-03-29

Related Finance Registrations

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.